328 related articles for article (PubMed ID: 30196334)
1. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
2. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components.
Vishram JK; Hansen TW; Torp-Pedersen C; Madsbad S; Jørgensen T; Fenger M; Lyngbæk S; Jeppesen J
Metab Syndr Relat Disord; 2016 Nov; 14(9):442-448. PubMed ID: 27676127
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study.
Moon SG; Park B
J Prev Med Public Health; 2022 Sep; 55(5):475-484. PubMed ID: 36229910
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study.
Park JH; Choi M; Kim JH; Kim J; Han K; Kim B; Kim DH; Park YG
Thyroid; 2020 Oct; 30(10):1496-1504. PubMed ID: 32524894
[No Abstract] [Full Text] [Related]
9. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
10. Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.
Lu Y; Ness-Jensen E; Hveem K; Martling A
Am J Epidemiol; 2015 Nov; 182(10):883-93. PubMed ID: 26511906
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
Aleksandrova K; Boeing H; Jenab M; Bas Bueno-de-Mesquita H; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Overvad K; Østergaard JN; Olsen A; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Masala G; Agnoli C; Panico S; Tumino R; Vineis P; Kaaks R; Lukanova A; Trichopoulou A; Naska A; Bamia C; Peeters PH; Rodríguez L; Buckland G; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Hallmans G; Palmqvist R; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Pischon T
Cancer Prev Res (Phila); 2011 Nov; 4(11):1873-83. PubMed ID: 21697276
[TBL] [Abstract][Full Text] [Related]
12. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
13. Elevated Neutrophil-to-Lymphocyte Ratio in Metabolic Syndrome Is Associated with Increased Risk of Colorectal Adenoma.
Kim JH; Cho KI; Kim YA; Park SJ
Metab Syndr Relat Disord; 2017 Oct; 15(8):393-399. PubMed ID: 28910195
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
[TBL] [Abstract][Full Text] [Related]
15. The relationship between metabolic syndrome and the incidence of colorectal cancer.
Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
17. Obesity-related parameters and colorectal adenoma development.
Kim TJ; Kim JE; Choi YH; Hong SN; Kim YH; Chang DK; Rhee PL; Kim MJ; Jung SH; Son HJ
J Gastroenterol; 2017 Dec; 52(12):1221-1229. PubMed ID: 28197803
[TBL] [Abstract][Full Text] [Related]
18. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
[TBL] [Abstract][Full Text] [Related]
19. Egg Consumption and Risk of Metabolic Syndrome in Korean Adults: Results from the Health Examinees Study.
Shin S; Lee HW; Kim CE; Lim J; Lee JK; Lee SA; Kang D
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28671590
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
